Stockreport

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024 [Yahoo! Finance]

Tenax Therapeutics, Inc.  (TENX) 
Last tenax therapeutics, inc. earnings: 11/14 04:31 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.tenaxthera.com
PDF treatment of pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) Presentation will occur at Technology and Heart Failure Therapeuti [Read more]